Corrigendum: Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 Patients (Front. Immunol., (2021), 12, (686240), 10.3389/fimmu.2021.686240)

Leila B. Giron, Harsh Dweep, Xiangfan Yin, Han Wang, Mohammad Damra, Aaron R. Goldman, Nicole Gorman, Clovis S. Palmer, Hsin Yao Tang, Maliha W. Shaikh, Christopher B. Forsyth, Robert A. Balk, Netanel F. Zilberstein, Qin Liu, Andrew Kossenkov, Ali Keshavarzian, Alan Landay, Mohamed Abdel-Mohsen

Research output: Contribution to journalComment/debatepeer-review

6 Scopus citations

Abstract

In the original article, there was a typo in Figure 1E, Supplementary Figure 3, and Supplementary Table 10 as published. The unit of the b-glucan should have been (pg/ml) instead of (ng/ml). The corrected Figure 1, Supplementary Figure 3, and Supplementary Table 10 appear below. (Firgure presented.) The authors apologize for this error and state that this does not change any of the scientific conclusions of the article in any way. The original article has been updated.

Original languageEnglish (US)
Article number779064
JournalFrontiers in immunology
Volume12
DOIs
StatePublished - Oct 4 2021
Externally publishedYes

Keywords

  • COVID-19
  • glycomics
  • inflammation
  • lipidomics
  • metabolomics
  • microbial translocation
  • SARS-CoV-2
  • zonulin

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint

Dive into the research topics of 'Corrigendum: Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 Patients (Front. Immunol., (2021), 12, (686240), 10.3389/fimmu.2021.686240)'. Together they form a unique fingerprint.

Cite this